Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation No phase listed Observational Accepts healthy volunteers

Alzheimer's Plasma Extension

ClinicalTrials.gov ID: NCT06416072

Public ClinicalTrials.gov record NCT06416072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 9:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this observational study is to learn how Alzheimer's disease-related blood biomarkers, brain amyloid, and memory and thinking abilities change over time. The study will include up to 3,000 people who previously did not qualify for an anti-amyloid Alzheimer's disease prevention trial based on their amyloid eligibility. Participants may have previously screened for the AHEAD 3-45 Study, A4 Study, or another anti-amyloid Alzheimer's disease prevention trial. The main questions this study aims to answer are: * Can Alzheimer's disease-related blood tests help predict future buildup of amyloid in the brain? * How are changes in Alzheimer's disease-related blood biomarkers related to changes in brain amyloid, memory, thinking, and self-reported cognitive function? * Do these changes differ based on factors such as sex, APOE genetic status, race, ethnicity, socioeconomic status, or social factors? Participants will be followed for about 6 years. They will complete memory and thinking assessments and questionnaires and provide blood samples. Some participants may also be asked to take part in optional activities, including brain imaging with positron emission tomography (PET) or magnetic resonance imaging (MRI), digital cognitive assessments, and questionnaires about habits and social factors.

Study identification

NCT ID
NCT06416072
Recruitment status
Enrolling by invitation
Study type
Observational
Phase
Not listed
Enrollment
3,000 participants

Conditions and interventions

Eligibility (public fields only)

Age range
55 Years to 80 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 21, 2023 (Actual)
Primary completion
Jun 2028 (Estimated)
Completion
Jun 2028 (Estimated)
Last update posted
Aug 18, 2026

2023 – 2028

United States locations

U.S. sites
56
U.S. states
30
U.S. cities
51
Facility City State ZIP Site status
University of Alabama, Birmingham Birmingham Alabama 35233 —
Banner Alzheimer's Institute Phoenix Arizona 85006 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
University of California, Irvine Irvine California 92697 —
University of Southern California Los Angeles California 90033 —
Stanford University Palo Alto California 94304 —
Sharp Neurocognitive Research Center San Diego California 92123 —
University of California, San Francisco San Francisco California 94158 —
University of California, Davis Walnut Creek California 94598 —
Yale University School of Medicine New Haven Connecticut 06510 —
Georgetown University Washington D.C. District of Columbia 20007 —
Howard University Washington D.C. District of Columbia 20060 —
Brain Matters Research Delray Beach Florida 33445 —
Mayo Clinic, Jacksonville Jacksonville Florida 32224 —
K2 Medical Research - The Villages Lady Lake Florida 32159 —
K2 Medical Research, LLC Maitland Florida 32751 —
Gonzalez MD & Aswad MD Health Services Miami Florida 33135 —
Wien Center for Clinical Research Miami Beach Florida 33140 —
Charter Research Orlando Florida 32803 —
University of South Florida - Health Byrd Alzheimer Institute Tampa Florida 33613 —
Emory University Atlanta Georgia 30322 —
Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
Indiana University Indianapolis Indiana 46202 —
University of Kansas Fairway Kansas 66205 —
University of Kentucky Lexington Kentucky 40504 —
Johns Hopkins University Baltimore Maryland 21224 —
Boston University Boston Massachusetts 02215 —
Brigham and Women's Hospital Boston Massachusetts 21155 —
Headlands Eastern MA LLC Plymouth Massachusetts 02360 —
University of Michigan, Ann Arbor Ann Arbor Michigan 48105 —
Mayo Clinic, Rochester Rochester Minnesota 55905 —
Washington University, St. Louis St Louis Missouri 63108 —
Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas Las Vegas Nevada 89101 —
Mount Sinai School of Medicine New York New York 10029 —
Columbia University New York New York 10032 —
University of Rochester Medical Center Rochester New York 14620 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Case Western Reserve University Beachwood Ohio 44122 —
Cleveland Clinic Lou Ruvo Center for Brain Health, Ohio Cleveland Ohio 44195 —
Ohio State University Columbus Ohio 43210 —
Central States Research, LLC Tulsa Oklahoma 74136 —
Oregon Health & Science University Portland Oregon 97239 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
Butler Hospital Memory and Aging Program Providence Rhode Island 02906 —
Ralph H. Johnson VA Health Care System Charleston South Carolina 29401 —
Vanderbilt University Medical Center Center for Cognitive Medicine Nashville Tennessee 37212 —
University of Texas, Southwestern MC at Dallas Dallas Texas 75390 —
Baylor College of Medicine Houston Texas 77030 —
Houston Methodist Neurological Institute Houston Texas 77030 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 —
Eastern Virginia Medical School at Old Dominion University Norfolk Virginia 23510 —
National Clinical Research Inc. Richmond Virginia 23294 —
University of Washington, Memory and Brain Wellness Center Seattle Washington 98195 —
University of Wisconsin Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06416072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 18, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06416072 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →